ISPOR - PMC18 THE ROLE OF CONCEPTUAL MODELS, ENDPOINT MODELS, AND CONCEPTUAL FRAMEWORKS WHEN MAKING TREATMENT BENEFIT CLAIMS TO THE FDA

PMC18 THE ROLE OF CONCEPTUAL MODELS, ENDPOINT MODELS, AND CONCEPTUAL FRAMEWORKS WHEN MAKING TREATMENT BENEFIT CLAIMS TO THE FDA

Abstract

Authors

D Wild C Donatti A Hareendran

Full Text Cite This Article

Back to Volume 10, Issue 6

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now